Intraperitoneal gene replacement therapy with a retroviral vector containing a wild type BRCA 1 gene results in growth inhibition and reduction of ovarian tumors in patients with ovarian cancer. We are focused on recruitment and follow up care with our patients.
Showing the most recent 10 out of 515 publications